首页/数据集/Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses

NIAID Data Ecosystem2026-03-11 收录

多发性硬化症药物疗效

单核细胞氧化反应

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130494 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

应用场景：

创建时间：

2020-04-10

多发性硬化症治疗

单核细胞氧化反应

Dimethyl fumarate (DMF) is a first-line-treatment for relapsing-remitting multiple sclerosis (RRMS). The redox master regulator Nrf2, essential in redox balance, is a target of DMF, but the precise th

NIAID Data Ecosystem80

The role of teriflunamide in multiple sclerosis patient: an observational study

多发性硬化症药物疗效

神经认知保护评估

Teriflunomide is a drug with immunosuppressive and selective immunomodulatory action, characterized by anti-inflammatory and antiproliferative properties. Several clinical studies have demonstrated th

Zenodo2022-02-16 更新30

Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database.docx

多发性硬化症药物疗效

真实世界医疗资源利用

Background: It is thought that older patients with multiple sclerosis (MS) may present with a different clinical disease phenotype, and therefore respond to subcutaneous interferon beta-1a (sc IFN β-1

NIAID Data Ecosystem20

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses [Illumina]

多发性硬化症治疗

单核细胞氧化反应

NIAID Data Ecosystem70

Efficacy of fingolimod stratified by previous DMT used.

多发性硬化症药物疗效

芬戈莫德分层分析

Efficacy of fingolimod stratified by previous DMT used.

NIAID Data Ecosystem30